EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case–Control Study

Paola Faverio iD, Paola Rebora, Giovanni Franco iD, Anna Amato iD, Nicole Corti, Katya Cattaneo, Simona Spiti, Umberto Zanini iD, Alessandro Maloberti iD, Cristina Giannattasio, Fabrizio Luppi iD, Valerio Leoni iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125790 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Paola Faverio und 11 weiteren Autor:innen. Beteiligte Einrichtung: U.O.C. di Pneumologia, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Lipid Metabolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione e del Merito, Italian Ministry of Universities and Research (MIUR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves complex interactions between epithelial, mesenchymal, immune, and endothelial cells, often aggravated by lipid metabolism dysfunction, mitochondrial, and peroxisomal abnormalities. Changes in lipid metabolism may drive fibrotic processes, suggesting the potential of lipid biomarkers for disease monitoring. We compared here the cholesterol metabolism and very-long-chain fatty acid profiles of patients with IPF with healthy controls. The IPF patients’ lipidic profiles were also evaluated according to disease severity and progression rate. This prospective, observational study involved 50 IPF patients at disease diagnosis before antifibrotic treatment initiation and 50 age- and gender-matched healthy controls. Using a serum lipidomic profile, we focused on cholesterol synthesis, mitochondrial and peroxisomal markers, inflammatory lipids, and oxidative stress markers. Disease severity was evaluated using the Gender-Age-Physiology (GAP) index, while the prognosis was assessed by classifying patients as rapid or slow progressors based on a 24-month follow-up. IPF patients exhibited lower levels of cholesterol synthesis precursors (e.g., lathosterol), mitochondrial oxysterols, and inflammatory mediators (e.g., arachidonic acid) compared to controls. Reduced levels of these biomarkers were also associated with higher disease severity and rapid disease progression. Conversely, some peroxisomal markers (e.g., brassidic acid and nervonic acid) showed altered trends depending on disease severity. Our findings indicate that patients with IPF, compared to healthy controls, may show lipidomic alterations, particularly a reduction in cholesterol precursors and docosahexaenoic acids, which are also associated with IPF severity and progression. While preliminary, this study suggests lipidomics to be a promising tool to stratify IPF severity and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisLipid MetabolismHumansFemaleMaleCase-Control StudiesPrognosisMiddle AgedAgedBiomarkersSeverity of Illness IndexDisease ProgressionCholesterolProspective StudiesLipidomicsMitochondria

Stichwörter der Autor:innen

idiopathic pulmonary fibrosislipidomicsmitochondriaperoxisomeprognosis

Substanzen

BiomarkersCholesterol

Autor:innen und Institutionen

  • U.O.C. di Pneumologia, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
  • School of Medicine and Surgery, Università degli Studi di Milano-Bicocca, 20100 Milan, Italy.
  • School of Medicine and Surgery, Bicocca Center of Bioinformatics, Biostatistics and Bioimaging (B4 Center), Università degli Studi di Milano-Bicocca, 20100 Milan, Italy.
  • Unit of Clinical Epidemiology and Biostatistics, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
  • Laboratory of Clinical Pathology, Hospital Pio XI of Desio, ASST-Brianza, 20832 Desio, Italy.
  • Cardiology IV, ASST Grande Ospedale Metropolitano Niguarda, 20100 Milan, Italy.

ORCID-Profile: Paola Faverio, Giovanni Franco, Anna Amato, Umberto Zanini, Alessandro Maloberti, Fabrizio Luppi, Valerio Leoni

Förderung

  • Ministero dell'Istruzione e del Merito
  • Italian Ministry of Universities and Research (MIUR)

Zitieren

APA

Faverio, P., Rebora, P., Franco, G., Amato, A., Corti, N., Cattaneo, K., Spiti, S., Zanini, U., Maloberti, A., Giannattasio, C., Luppi, F., & Leoni, V. (2025). Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case–Control Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125790

Vancouver

Faverio P, Rebora P, Franco G, Amato A, Corti N, Cattaneo K, et al. Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case–Control Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125790

BibTeX
@article{Faverio2025,
  author = {Faverio, Paola and Rebora, Paola and Franco, Giovanni and Amato, Anna and Corti, Nicole and Cattaneo, Katya and Spiti, Simona and Zanini, Umberto and Maloberti, Alessandro and Giannattasio, Cristina and Luppi, Fabrizio and Leoni, Valerio},
  title = {Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case–Control Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125790}
}
Kostenlos starten →